(–)-2β-(3-Methylisoxazol-5-yl)-3β-(p-tolyl)tropane (RTI-171) is a phenyltropane derivative which acts as a selective dopamine reuptake inhibitor with a relatively slow onset of action and short duration of effects found in animal studies.
This page contains content from the copyrighted Wikipedia article "RTI-171"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.